Use and availability of anti‐ RhD immunoglobulin in Colombia following the 2024 national shortage

Documenti analoghi

• Non‐invasive foetal RhD genotyping: A strategy for rationalizing anti‐D immunoglobulin prophylaxis in RhD ‐negative pregnant women at the Hospital Italiano de Buenos Aires
  di: Diego Mario Santoro, et al.
  Pubblicazione: (2025)
• Prediction of the antigenic regions in eight RhD variants identified by computational biology
  di: Rocio Trueba‐Gómez, et al.
  Pubblicazione: (2024)
• Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients
  di: María‐Isabel Bermúdez‐Forero, et al.
  Pubblicazione: (2024)
• Nucleic acid testing in Colombian blood banks (2018–2024): Implementation, yield estimates and implications for safer transfusion policy
  di: María‐Isabel Bermúdez‐Forero, et al.
  Pubblicazione: (2025)
• RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study
  di: Takaaki Konuma, et al.
  Pubblicazione: (2024)